Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
about
The steady progress of targeted therapies, promising advances for lung cancerFrom Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung CancersHistone methyltransferases: novel targets for tumor and developmental defectsPredictive biomarkers in precision medicine and drug development against lung cancerAdhesion GPCRs in Tumorigenesis.Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsyAbility to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Role of several histone lysine methyltransferases in tumor development.FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies.Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine.Elevated expression of STIM1 is involved in lung tumorigenesis.Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues.Inhibitors of Protein Methyltransferases and Demethylases.Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy.Renal oncocytoma characterized by the defective complex I of the respiratory chain boosts the synthesis of the ROS scavenger glutathione.Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.[Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin.
P2860
Q26746895-464CABFA-00A6-4DAE-9D24-D093B2B54F76Q26771375-41997E89-9ABA-4B54-ADB4-F7B871DEC051Q26775027-6BD9380B-9B4F-4B0C-88C5-8C3E8A1BD984Q26824536-342D6038-C8D9-4332-8FBE-34BB465D145DQ33558191-DF59FA39-6D6F-45DD-806B-0BD50963DE4AQ33821373-275D4DD0-361D-4F1D-85E8-94335625D28CQ35760892-22B7EED6-6A84-44B3-A4D5-0AF59184F148Q35885771-1319D841-BC24-4FA2-8DF3-40029D7AA475Q36633405-F734750E-4FA4-475A-8D63-612ABA303C44Q36639797-D0D1CB7F-BD5C-4237-8988-96B1FE39CA1AQ37164249-7A54CC78-BF13-4DD5-81FB-0666C4B3B8DEQ37592628-59C8D936-FA16-4AD4-80F9-5DBA6D2F0694Q37699292-DC2F7A3C-E8E6-4780-B453-AD707B45AFAEQ37706884-1CA94E9F-3B40-4595-8E98-63F89D6AC4A2Q38594002-68993D86-BA0A-4F65-AFCB-8AA1FDD45753Q38659180-C217BAD1-F434-41A1-BA45-FEB06B82C854Q38740496-8EE24E17-1DF5-4467-AA99-D8592BCB16CFQ38740566-17C1DF53-F587-41F7-89C7-4D8B6A098247Q38793093-270E8835-75D6-4C63-88B8-738D6EC69C15Q41158938-37A21EBD-F098-41CA-B1F9-6E27CCBB45E2Q46754175-6C12D121-33CB-4C61-8CA3-0B353D997F2EQ47131093-D43FB909-069F-4FD1-949B-5D6AB5103851Q48233659-A100A846-D014-42EC-AA85-C81A69D287E2Q50072133-E2BD8366-D8E1-478B-965B-7170181C7BC6Q54978516-1208FDD1-328E-4EE1-A275-11F7831FCCD4Q55155270-A79C785E-C8FB-4087-B4C2-9D4C336A024F
P2860
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@ast
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@en
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@nl
type
label
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@ast
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@en
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@nl
prefLabel
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@ast
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@en
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Gene mutations in primary tumo ...... om non-small cell lung cancer.
@en
P2093
Agda Karina Eterovic
Apar Pataer
Ara Vaporciyan
Bingliang Fang
Boris Sepesi
Chuncheng Hao
David Rice
Faye M Johnson
Garrett L Walsh
P2860
P304
P356
10.1016/J.CANLET.2014.11.024
P407
P577
2014-11-18T00:00:00Z